195 related articles for article (PubMed ID: 22101425)
1. DOCUMENT: a system for classifying drug-related problems in community pharmacy.
Williams M; Peterson GM; Tenni PC; Bindoff IK; Stafford AC
Int J Clin Pharm; 2012 Feb; 34(1):43-52. PubMed ID: 22101425
[TBL] [Abstract][Full Text] [Related]
2. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.
Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD
Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658
[TBL] [Abstract][Full Text] [Related]
3. Drug-related problems in prescribed medicines in Germany at the time of dispensing.
Nicolas A; Eickhoff C; Griese N; Schulz M
Int J Clin Pharm; 2013 Jun; 35(3):476-82. PubMed ID: 23605073
[TBL] [Abstract][Full Text] [Related]
4. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
Krähenbühl JM; Kremer B; Guignard B; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
[TBL] [Abstract][Full Text] [Related]
5. Survey of drug-related problems identified by community pharmacies.
Hämmerlein A; Griese N; Schulz M
Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of drug-related problems documented in a national database.
Westerlund T; Gelin U; Pettersson E; Skärlund F; Wågström K; Ringbom C
Int J Clin Pharm; 2013 Apr; 35(2):202-9. PubMed ID: 23187961
[TBL] [Abstract][Full Text] [Related]
7. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.
Williams M; Peterson GM; Tenni PC; Bindoff IK
Int J Pharm Pract; 2012 Aug; 20(4):238-48. PubMed ID: 22775520
[TBL] [Abstract][Full Text] [Related]
8. Drug related problems identified by community pharmacists on hospital discharge prescriptions in New Zealand.
Braund R; Coulter CV; Bodington AJ; Giles LM; Greig AM; Heaslip LJ; Marshall BJ
Int J Clin Pharm; 2014 Jun; 36(3):498-502. PubMed ID: 24700340
[TBL] [Abstract][Full Text] [Related]
9. Completeness of medication reviews provided by community pharmacists.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2014 Jun; 39(3):248-52. PubMed ID: 24521180
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.
Szilvay A; Somogyi O; Meskó A; Zelkó R; Hankó B
BMC Health Serv Res; 2019 May; 19(1):282. PubMed ID: 31053135
[TBL] [Abstract][Full Text] [Related]
11. Analysis of community chain pharmacists' interventions on electronic prescriptions.
Warholak TL; Rupp MT
J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
[TBL] [Abstract][Full Text] [Related]
12. Documentation of drug related problems and their management in community pharmacy: Data evolution over six years.
Amador-Fernández N; Baechler T; Quintana-Bárcena P; Berger J
Res Social Adm Pharm; 2023 Nov; 19(11):1480-1485. PubMed ID: 37481352
[TBL] [Abstract][Full Text] [Related]
13. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
Desmaele S; De Wulf I; Dupont AG; Steurbaut S
Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
[TBL] [Abstract][Full Text] [Related]
14. Drug related problems identified by European community pharmacists in patients discharged from hospital.
Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
[TBL] [Abstract][Full Text] [Related]
15. Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands.
van Loon WEE; Borgsteede SDS; Baas GWG; Kruijtbosch MM; Buurma HH; De Smet PAGMP; Egberts ACGT; Bouvy MM; Floor-Schreudering AA
Br J Clin Pharmacol; 2021 Mar; 87(3):1455-1465. PubMed ID: 32901959
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical care research and education project: pharmacists' interventions.
Kassam R; Farris KB; Burback L; Volume CI; Cox CE; Cave A
J Am Pharm Assoc (Wash); 2001; 41(3):401-10. PubMed ID: 11372905
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
18. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical care in community pharmacies: practice and research in Sweden.
Westerlund LT; Björk HT
Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
[TBL] [Abstract][Full Text] [Related]
20. Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
Eichenberger PM; Lampert ML; Kahmann IV; van Mil JW; Hersberger KE
Pharm World Sci; 2010 Jun; 32(3):362-72. PubMed ID: 20229029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
